Conavi Medical Corp. (TSXV:CNVI)
Canada
· Delayed Price · Currency is CAD | Market Cap | 29.21M |
| Revenue (ttm) | 2.16M |
| Net Income (ttm) | -43.62M |
| Shares Out | 44.25M |
| EPS (ttm) | -7.08 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,127 |
| Average Volume | 6,304 |
| Open | 0.780 |
| Previous Close | 0.720 |
| Day's Range | 0.750 - 0.780 |
| 52-Week Range | 0.500 - 1.520 |
| Beta | n/a |
| RSI | 39.87 |
| Earnings Date | Mar 7, 2025 |
About Conavi Medical
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada. [Read more]
Financial Performance
In 2024, Conavi Medical's revenue was 2.16 million, a decrease of -8.59% compared to the previous year's 2.36 million. Losses were -43.62 million, 67.2% more than in 2023.
Financial StatementsNews
Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination
TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“the “Resulting Issuer” or the “Corporation”) (TSX: TMD; OTC: TMDIF) is pleased to announce the comple...
Titan Announces the Closing of Conavi's Private Placement of Subscription Receipts and Provides Update on the Transaction
TORONTO, Ontario, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that, in connection with its amalgamation agreement (“Amalgamation Agreem...
Titan Announces Resignations of Directors
TORONTO, Ontario, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that following its annual general meeting held on September 30, 2024 (the “Meeting”) a...
Titan Reports Voting Results from 2023 Annual General and Special Meeting
TORONTO, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announced the voting results from its Annual General and Special Meeting of Shareholders (the “...
Titan Medical begins process to move to the TSX Venture Exchange
TORONTO, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that its board of directors (the “Board”) has approved the voluntary delisting (the “...
Conavi Medical Shareholders Approve the Proposed Amalgamation Between Titan and Conavi
Titan's respective annual general and special meeting of shareholders to vote on the amalgamation transaction to take place on September 30, 2024, at 4:00 p.m. Eastern Time Titan's respective annual g...
Proxy Deadline Thursday September 26, 2024
TORONTO, Ontario, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) released a reminder for shareholders to vote ahead of Titan's annual and special shareholders m...
Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
TORONTO, Ontario, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that a second independent proxy advisor, Glass Lewis has recommended tha...
Independent Proxy Advisor, Institutional Shareholder Services (“ISS”), Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
TORONTO, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that Institutional Shareholder Services (“ISS”), has released a report (...
Titan Announces Conavi Medical to Present Overview at Titan Q&A Session
TORONTO, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that Conavi Medical Inc. (“Conavi”) will be joining the previously announced Titan Q&...
Titan Announces Q&A Session with Shareholders
TORONTO, Ontario, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that Titan management will host a webcast Q&A session on Thursday, September 19, 2024...
Titan Announces Filing of the Management Information Circular.
TORONTO, Ontario, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce the filing and mailing of its management information circular (the “Circ...
Titan Medical Reports Operating and Financial Results for the Second Quarter 2024
TORONTO, Ontario, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three and six months ended June 30, 2...
Titan Further Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Further Extension of 2024 Annual General and Special Meeting
TORONTO, Ontario, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into a third amending agreement dated August 13, 2024...
Titan Amends Amalgamation Agreement with Conavi Medical Inc.
TORONTO, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that it has entered into a second amending agreement dated July 5, 2024 (the “Amending...
Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting
TORONTO, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into an amending agreement dated May 28, 2024 (the “Am...
Titan Provides Update on Planned Merger with Conavi
TORONTO, Ontario, May 17, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is providing an update on its planned merger with Conavi Medical Inc. (“Conavi”) pursuant to the ...
Titan Medical Reports Financial Results for the First Quarter 2024
TORONTO, Ontario, May 13, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three months ended March 31, 2024.
Titan Settles Contractual Dispute with Contract Manufacturer
TORONTO, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that it has entered into a settlement agreement with a contract manufacturer (“Contra...
Titan Medical Reports Fiscal Year 2023 Results
TORONTO, Ontario, March 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the fiscal year ended December 31, 2023.
Titan Announces Merger Agreement with Conavi
- Merger to create publicly-listed, commercial-stage leader in hybrid intravascular imaging - - Merger to create publicly-listed, commercial-stage leader in hybrid intravascular imaging -
Titan Medical to Report Year-End 2023 Financial Results on March 29, 2024
TORONTO, Ontario, March 04, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today that the Company plans to issue its year-end 2023 financial r...
Titan Medical Announces Benchmark Electronics, Inc. Purported to Terminate Agreement
TORONTO, Ontario, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today that Benchmark Electronics, Inc., the company engaged by Titan...
Titan Medical Reports Operating and Financial Results for the Third Quarter 2023
TORONTO, Ontario, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today financial results for the three and nine months ended Septembe...
Titan Medical Announces Change in Auditor
TORONTO, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), a medical technology company, announces that it has changed its auditor from B...